Chronic Interstitial Nephritis in Agricultural Communities (CINAC)

Earn CME/CE in your profession:


Continuing Education Activity

Chronic interstitial nephritis in agricultural communities is a new form of chronic kidney disease. Its etiology is not linked to diabetes, hypertension, glomerulopathies, or other known causes of renal diseases. It had reached epidemic proportions in Central America, Sri Lanka, and other tropical countries. It was reported mainly in young men, occasionally women, and adolescents. The causes are potentially preventable and must be promptly diagnosed and treated to avoid the high morbidity associated with this condition. This activity examines the etiology and diagnosis of this condition and highlights the role of the interprofessional team in managing patients with chronic interstitial nephritis in agricultural communities to ensure the best patient outcomes.

Objectives:

  • Review the epidemiological characteristics of chronic interstitial nephritis in agricultural communities.
  • Describe the etiology of chronic interstitial nephritis in agricultural communities.
  • Outline the histopathological findings in patients with chronic interstitial nephritis in agricultural communities.
  • Explain how the interprofessional team can manage chronic interstitial nephritis in agricultural communities to ensure the best patient outcomes.

Introduction

Chronic interstitial nephritis in agricultural communities (CINAC) is a new form of chronic kidney disease (CKD) with its own etiopathogenesis; not related to other well-known causes of CKD such as diabetes, hypertension, and glomerulopathies.[1] However, the incidence and prevalence of CINAC have reached epidemic proportions. Predominantly, CINAC affects young men but has also been occasionally reported in women and adolescents in countries such as El Salvador, Guatemala, Nicaragua, and Costa Rica in Central America, Egypt in Africa, and Sri Lanka and India in Asia.[2]

This form of CKD of nontraditional causes has been reported from several world regions and has similar clinical and epidemiological characteristics.[3][4] It is known by various names, such as Central American nephropathy, Salvadoran agricultural nephropathy, Mesoamerican nephropathy, Uddanam endemic nephropathy (India), or CKD of unknown etiology (CKDu) in Srilanka.[5] The term chronic interstitial nephritis in agricultural communities (CINAC) was proposed to describe the disease holistically.[4] 

CINAC affects people working in the agricultural sectors of these regions, which are described as CINAC endemic areas.

The socio-economic and occupational determinants such as poverty, exposure to toxic agrochemicals, and hot tropical climates correlate with clinical characteristics that help make the diagnosis. The disease most frequently occurs in men and affects women, children, and adolescents who live in these farming communities. In endemic regions, CINAC is noted even in those who do not work in agriculture.[6]

In fact, according to The Pan American Health Organization, Nicaragua and El Salvador have CKD-related estimated mortality rates of 42.8 and 41.6 deaths per 100,000, respectively, which is fourfold higher than any other country. In El Salvador, CKD is the second most common cause of death in young men, with males affected three times more than females.[7]

Etiology

The etiology of chronic interstitial nephritis in agricultural communities remains unknown. A disease with unusual clinical behavior would also be expected to have unusual risk factors, etiologies, and pathophysiologic mechanisms. Chronic kidney disease (CKD) is traditionally etiologically associated with diabetes mellitus and hypertension in most cases and, to a lesser degree, with primary or secondary kidney diseases.

However, a form of CKD affects agricultural communities in endemic and epidemic proportions. It is found particularly among male farmers, presents at a young age, and affects a proportionately lower number of non-farming women and adolescents. In addition, this form is associated with functional changes and biomarkers of kidney damage among children in these communities. These characteristics suggest risk factors associated with the environment in these communities and the occupations of their residents, implying several etiologic factors working in conjunction with a predominant one.  

Residents in these agricultural communities are exposed to the same risk factors as the world’s general population. Additionally, their occupations expose them to multiple toxic substances, many of which have been outlawed in other countries.[8] These chemicals are used in large quantities, mixed and applied without personal protective gear, and over prolonged workdays. Working conditions include elevated ambient temperatures and intense physical activity with suboptimal hydration.  

One hypothesis might be that disease is associated with toxic agents (heavy metals ab, chemicals, or microbial substances) in the environment from either natural or artificial sources.[9] These toxins could be present in the air, soil, water, and/or food. Additionally, exposure to a toxin can be modified by climate, topography, and soil use. Lifestyles, working conditions, and impurities in drinking water could determine the route of exposure.[10] A patient may have exposure to the toxin via inhalation, ingestion, or skin contact. Therefore, exposure exists on a spectrum, from high-level through repeated exposures affecting primarily farmers to low-level through chronic exposure affecting the general population. In both cases, genetic susceptibility could be a conditioning factor, but it has not been studied yet. Circulation of toxic agents in the blood is subject to renal elimination, which may become compromised in a state of recurrent dehydration in farmworkers. Some studies report that elevated levels of fluoride and vanadium in the environment could be associated with an increasing prevalence of CINAC.[11]

It is hypothesized that the toxins cause direct tubular cell toxicity. Secondary tubular damage occurs due to alterations of the renal blood flow due to environmental conditions.[12][13]

Additional factors that make the farmworkers and surrounding communities vulnerable to kidney damage are low birth weight, infectious diseases such as malaria, diabetes, hypertension, obesity, smoking, excessive alcohol consumption, non-steroidal anti-inflammatory drugs, dehydration, and nephrotoxic medicinal plants.[14]

Another hypothesis for the etiology of CINAC is recurrent dehydration.[15] Repeated dehydration events have been proposed to cause sub-clinical rhabdomyolysis, effects of hyperuricosuria and hyperuricemia, activation of the aldose reductase-fructokinase reaction in the kidney, and vasopressin effects.[16][17][18] However, in hotter areas where agrochemicals are rarely or never used, CINAC is absent. In addition, experiments in rats demonstrated that dehydration/heat stress over four weeks does not induce the dysmorphic lysosomes identified in patients with CINAC.

More studies need to be done; nonetheless, it appears from indirect observations that CINAC is the pathologic expression of a toxic insult.[19]

Epidemiology

Twenty years after reporting the first case, chronic interstitial nephritis in agricultural communities is a significant public health issue in many countries, such as Central America, Sri Lanka, etc. It is estimated that the North Central Province (NCP) in Sri Lanka has more than 60000 estimated cases and more than 20000 annual deaths. The available CINAC statistics from hospital records reveal a steady rise in cases from 2000 to 2015. Between 2000 and 2002, the underlying cause of kidney failure was not found in 82% of CKD cases seen at Anuradhapura teaching hospital.[20] The World Health Organization (WHO) study group reported a slightly higher age-standardized prevalence of CINAC in women than men but observed that more advanced CINAC was seen more commonly in men.[21] This is in line with the well-known higher prevalence of advanced CKD among men, as noted in many studies.[22]

Many epidemiological studies have shown CKD prevalence in farming communities. Less than half of them have diabetes mellitus or hypertension, males predominate, and kidney damage begins in the early stages of life. While the disease predominantly affects men, other community members, such as women, children, and adolescents in these farming communities, are also affected whether they work on the farms or not. This increased prevalence of CKD has been observed in farming communities both in highlands and lowlands.[23][24]

Additionally, it has been demonstrated that in these farming communities, pesticides and heavy metals (cadmium and arsenic) are present in well water, floors in homes, and farmlands (more concentrated in crop areas). Farmers that contaminate their clothes with pesticides (due to lack of protection) provide additional exposure to the family, especially to women who wash family clothing. In the United States, a cohort of 55,580 male licensed pesticide applicators showed a significant association between chronic pesticide exposure and the risk for chronic kidney disease.[25]

An epidemic of CKD not linked with conventional risk factors has been observed in places like India, Japan, Central America, and Sri Lanka.[26] In India, numerous cases have been diagnosed among coconut and paddy farmers.

In Central America, increasing numbers of CKD cases and increased CKD-associated mortality have been noted over the last two decades, especially in El Salvador and Nicaragua. The Pan American Health Organization has reported CKD-specific mortality rates (per 100 000 population) as follows: Nicaragua: 42.8; Guatemala: 13.6; El Salvador: 41.9; and Panama: 12.3.

Pathophysiology

Chronic interstitial nephritis in agricultural communities is one of the causes of chronic kidney disease of unknown etiology, which is generally more frequently seen in certain agricultural communities, as described above. Regarding the underlying pathophysiology of CINAC, two triggers have been proposed: toxic exposure in agricultural communities and heat stress with repeated episodes of dehydration causing recurrent acute kidney injury leading to CKD.[19] 

It is plausible that heat stress is an important contributor to the perpetuation of CINAC but is unlikely to be the sole driving force because CINAC is absent in very hot areas such as Cuba, Myanmar, and Northern Sri Lanka, where agrochemicals are rarely used. The identical clinical and pathologic phenotype of CINAC in different locations supports the involvement of common pathophysiological pathways. The patients treated with calcineurin inhibitors (CNI) acquire similar lesions in their proximal tubule cells. There is documented CNI effect of some herbicides and insecticides (paraquat, glyphosate, and pyrethroids). These findings strongly suggest a toxicologic etiology for the presence of CINAC.[19]

Roncal-Jimenez et al. pointed out that recurrent dehydration may lead to renal injury by activating the polyol pathway, causing the production of endogenous fructose in kidneys that subsequently induces renal injury through metabolism by fructokinase. Fructose is nontoxic; however, fructokinase metabolizes it to generate uric aid, nephrotoxic oxidants, and inflammatory mediators. The major area where fructokinase is abundantly expressed is in the proximal tubules. Recurrent dehydration leads to repeated aldose reductase stimulation, causing fructose generation in the proximal tubules, resulting in tubular injury and inflammation. In some instances, agricultural laborers commonly use fructose-containing beverages for rehydration. A recent animal study revealed pathology suggestive of CINAC, such as elevated serum creatinine, renal inflammation, proximal tubular injury, and fibrosis after repeated exposure to heat-induced dehydration. Interestingly, this pathology was not observed in fructokinase-deficient mice. Additionally, another animal study reported that access to sufficient and clean water during the period of dehydration could protect the kidney.[18]

One hypothesis for the damage could be the continued farmers' exposure to toxic substances without protection during the spraying at high temperatures that cause vasodilation and opening of the skin pores, causing an increment in the absorption and selective damage to the different organs, leading to reflex disorders, sensorineural hearing loss, and chronic kidney disease.[19]

Environmental/occupational toxic exposure is more credible as the main driver of this epidemic.[27] Genetic susceptibility was identified as a risk factor for CINAC using a genome-wide association study (GWAS) in Sri Lanka.[28]

Histopathology

Histologic findings in chronic interstitial nephritis in agricultural communities cases from different regions of the world are similar. There is tubular atrophy, interstitial fibrosis, and a variable interstitial mononuclear inflammatory infiltrate. There may be associated global glomerulosclerosis, glomerulomegaly, ischemic-appearing glomerular capillary wall corrugation, and features of vascular injury, including muscular hypertrophy, smooth muscle vacuolization, and intimal proliferation within arteries and arterioles.[29][30][31] 

The predominant pattern shows chronic tubulointerstitial nephritis with argyrophilic granules (identified as lysosomes) in enlarged proximal tubular cells associated with varying degrees of epithelial simplification and tubular atrophy and luminal cell fragment shedding with or without a tubulointerstitial expansion (inflammation, edema, fibrosis).[32]

Electron microscopy: Confirmatory diagnosis is established in the presence of enlarged (> 1.2 mm) dysmorphic lysosomes containing electron-dense aggregates. In the absence of enlarged lysosomes, the diagnosis should be suspected if there are two or more clusters of 3 lysosomes that have intra-lysosomal aggregates.[32]

History and Physical

The clinical picture of chronic interstitial nephritis in agricultural communities is similar in many areas. CINAC progresses slowly but at a varying pace based on the level of exposure to agrochemicals/herbicides and/or contaminated water. In the majority of cases, there are no symptoms at the beginning of the disease.[8] Some general symptoms reported at the outset are arthralgia, asthenia, muscle cramps, decreased libido, and faintishness.[33] Proteinuria is rare and moderate. Renal function tests reveal polyuria accompanied by hyperphosphaturia, hypermagnesuria, hypernatriuria, hyperkaliuria, and hypercalciuria.[34]

Urinary symptoms include the following:

  • Nocturia
  • Dysuria
  • Post-void dribbling
  • Hesitancy
  • Foamy urine

Symptoms appear as early as stage 2 CKD, and the frequency and intensity of symptoms progress as the disease advances. However, at times decreased urine stream, hesitancy, and dysuria are evident from the start.

Patients may also present with extrarenal symptoms when different organs and systems are also affected, while others show no sign of damage.

  • Cardiovascular system: blood pressure is either normal or mildly elevated, and electrocardiogram (ECG) is mostly normal. The cardiac stress test, pressor response, and echocardiogram are normal in most cases, whereas mild diastolic dysfunction can be noted. CINAC patients in El Salvador showed few abnormalities of the aortoiliac and carotid arteries but significant tibial artery abnormalities.[33]
  • Peripheral arteries: Doppler ultrasound describes a few abnormalities of the carotid and aortoiliac arteries; most of the damage is seen in the tibial arteries. The most common tibial lesion has been reported to be wall irregularities.
  • Nervous system: tendon reflex abnormalities are seen in the early stages and sensorineural hearing loss. Both heavy metals and organic solvents are observed to cause sensorineural hearing loss.[35]
  • Eyes: fundoscopic examination, intraocular pressure, and visual field tests are normal in most patients, suggesting that these patients do not have significant microvascular damage as in diabetic or hypertensive retinopathy.

Evaluation

There are many ways to narrow down differentials and establish a diagnosis of chronic interstitial nephritis in agricultural communities. The following is the list of investigations needed to diagnose CINAC:

Laboratory Evaluation

Laboratory studies include complete blood count (CBC), comprehensive metabolic panel (CMP), magnesium level, total urine protein, urine sodium range, urine potassium range, urine magnesium range, 24-hour urine, urine protein-creatinine ratio, and urine tubular proteins. The sediment neither shows significant abnormalities nor dysmorphic erythrocytes in the urine assessment. Loss of electrolytes in the early stage, low to mild proteinuria (<1 g), and high levels of beta 2 microglobulin are found.[36][37]

Electrolytes: low concentrations of sodium, potassium, chlorine, and magnesium in the blood; nevertheless, blood osmolality remains normal. 

Acid-base imbalance: metabolic alkalosis is predominant, starting as early as stage 2 CKD.

Imaging

Kidney ultrasound reveals an increased echogenicity, decreased cortical-medullary ratio, and irregular margins.[4] Renal Doppler ultrasound shows preserved blood flow in renal and segmental arteries and the renal parenchyma. Bladder ultrasound shows no abnormalities, and prostate ultrasound is normal without masses or other lesions.

Cardiological Evaluation

Electrocardiogram, echocardiogram, Doppler ultrasound of the leg, and carotid doppler test might be warranted in patients varying from one case to another.

Renal Evaluation

Renal function tests, biopsy with immunofluorescence, electron microscopy, and light microscopy could be carried out to establish the diagnosis.

Neurological Evaluation

Electromyography and nerve conduction studies may be needed. 

Treatment / Management

Early detection and prevention of further deterioration of kidney function is the cornerstone of therapy in chronic interstitial nephritis in agricultural communities. The most important early step is to move the patient away from agrochemical contact. In addition, supportive care with fluids and electrolytes, adequate hydration, and correction of electrolyte abnormalities are important in early-stage management. Once chronic kidney disease has developed, the patient is generally managed on the lines of chronic kidney disease secondary to other causes. In the final stage of chronic kidney disease, renal replacement therapy should be implemented.

The recent findings suggestive of a lysosomal inclusion body tubulopathy are of great interest to those trying to find therapeutic options to slow down or eliminate the renal damage. It has been argued that despite these findings, oxidative stress might play a key role and that anti-oxidants could be a pertinent treatment option, such as Vitamin C and E.[38]

CINAC prevention measures can include establishing reverse osmosis plants to purify the water and lessen the exposure to possible nephrotoxins via drinking water.[39]

Poor awareness and agrochemical handling practices lead to occupational exposure; hence focusing on farming practices, lifestyle, agrochemical handling, and awareness of health effects could prevent this disease.

Differential Diagnosis

The following is a list of differentials that merit consideration when dealing with a patient having features suggestive of chronic interstitial nephritis in agricultural communities:

  • Analgesic nephropathy
  • Aristolochic acid nephropathy
  • Balcan endemic nephropathy
  • Lithium poisoning
  • Lead poisoning
  • Cadmium poisoning
  • Hyperuricemia and urate nephropathy
  • Nephropathy secondary to sarcoidosis
  • Nephropathy secondary to calcineurin inhibitors

Prognosis

The prognosis of chronic interstitial nephritis in agricultural communities depends on the degree of renal dysfunction (GFR reduction) at the time of diagnosis and treatment options for the underlying condition. It also depends on the patient's past medical history, comorbidity, and general health. The progression of renal dysfunction is relatively rapid, with end-stage renal disease occurring over 4 to 10 years.[19] A study reported excess CKD mortality primarily in Guanacaste lowlands, and the increasing rates in Guanacaste population in hot and dry lowland counties with sugarcane were consistent with an occupational component.[40]

Complications

In patients with chronic interstitial nephritis in agricultural communities, older patients are more susceptible to complications. Delays in diagnosis and treatment worsen the condition. Renal insufficiency is a common manifestation that ultimately progresses to end-stage renal disease. The inflammatory interstitium is completely replaced by fibrosis, and severe degeneration of tubular epithelial cells induces irreversible renal impairment necessitating early renal dialysis and renal transplantation. Some complications are neurologic (reflex alterations in the early stage), auditive (hypoacusis), and vascular lesions in the lower limbs.[4]

Deterrence and Patient Education

Chronic interstitial nephritis in agricultural communities calls for careful health education. The occupational health team can play important roles in recognizing kidney disease risks among agricultural workers, advocating for prevention strategies such as using pesticides according to federal regulations, use of PPE, shade, rest, and water supply to prevent heat stress, dehydration, and volume depletion.

Occupational and community health teams should assess work, and it is essential to identify patient occupation, provide guidance in the management of pain to prevent overuse of NSAIDs, educate patients on the potential risks of self-treatment with antibiotics for urinary symptoms, and encourage them to seek professional care to decrease the risk of acute kidney injury.

CKD screening in high-risk patients based on their medical and occupational history should include the history of prior occupation, such as farm work, type of crops, spraying of pesticides, and sugar cane cutting.

Enhancing Healthcare Team Outcomes

Chronic interstitial nephritis in agricultural communities is a complex disease that develops in susceptible individuals working in agriculture. The hypothesized causal factors can be minimized and may be preventable. Therefore, it is critical to have an interprofessional collaboration and multidisciplinary/interprofessional approach that seeks to strengthen health services, workforce training, health technology, medical surveillance, and increase medication supply with international cooperation. As a relatively recently recognized condition, interprofessional communication between clinicians (MDs, DOs, NPs, and PAs), specialists, nursing staff, and pharmacists is crucial because some team members may not be familiar with the disease or how to monitor and treat it. Therefore, additional training may be necessary for providers who come onto the case management team, and all members must understand the condition, monitor patient progress, and document their findings and observations so everyone managing the case can have access to current and accurate patient data. This interp[professional approach will help drive better outcomes. [Level 5]



(Click Image to Enlarge)
CINAC case 1
CINAC case 1
Contributed by Cynthia Nast, MD Renal Pathology Cedars Sinai
Details

Editor:

Sami M. Akram

Updated:

6/20/2023 10:24:34 PM

References


[1]

GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, Aboyans V, Abraham JP, Abubakar I, Abu-Raddad LJ, Abu-Rmeileh NM, Achoki T, Ackerman IN, Ademi Z, Adou AK, Adsuar JC, Afshin A, Agardh EE, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Alla F, Allebeck P, Almazroa MA, Alsharif U, Alvarez E, Alvis-Guzman N, Amare AT, Ameh EA, Amini H, Ammar W, Anderson HR, Anderson BO, Antonio CA, Anwari P, Arnlöv J, Arsic Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Avila MA, Awuah B, Bachman VF, Badawi A, Bahit MC, Balakrishnan K, Banerjee A, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Basu A, Basu S, Basulaiman MO, Beardsley J, Bedi N, Beghi E, Bekele T, Bell ML, Benjet C, Bennett DA, Bensenor IM, Benzian H, Bernabé E, Bertozzi-Villa A, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bienhoff K, Bikbov B, Biryukov S, Blore JD, Blosser CD, Blyth FM, Bohensky MA, Bolliger IW, Bora Başara B, Bornstein NM, Bose D, Boufous S, Bourne RR, Boyers LN, Brainin M, Brayne CE, Brazinova A, Breitborde NJ, Brenner H, Briggs AD, Brooks PM, Brown JC, Brugha TS, Buchbinder R, Buckle GC, Budke CM, Bulchis A, Bulloch AG, Campos-Nonato IR, Carabin H, Carapetis JR, Cárdenas R, Carpenter DO, Caso V, Castañeda-Orjuela CA, Castro RE, Catalá-López F, Cavalleri F, Çavlin A, Chadha VK, Chang JC, Charlson FJ, Chen H, Chen W, Chiang PP, Chimed-Ochir O, Chowdhury R, Christensen H, Christophi CA, Cirillo M, Coates MM, Coffeng LE, Coggeshall MS, Colistro V, Colquhoun SM, Cooke GS, Cooper C, Cooper LT, Coppola LM, Cortinovis M, Criqui MH, Crump JA, Cuevas-Nasu L, Danawi H, Dandona L, Dandona R, Dansereau E, Dargan PI, Davey G, Davis A, Davitoiu DV, Dayama A, De Leo D, Degenhardt L, Del Pozo-Cruz B, Dellavalle RP, Deribe K, Derrett S, Des Jarlais DC, Dessalegn M, Dharmaratne SD, Dherani MK, Diaz-Torné C, Dicker D, Ding EL, Dokova K, Dorsey ER, Driscoll TR, Duan L, Duber HC, Ebel BE, Edmond KM, Elshrek YM, Endres M, Ermakov SP, Erskine HE, Eshrati B, Esteghamati A, Estep K, Faraon EJ, Farzadfar F, Fay DF, Feigin VL, Felson DT, Fereshtehnejad SM, Fernandes JG, Ferrari AJ, Fitzmaurice C, Flaxman AD, Fleming TD, Foigt N, Forouzanfar MH, Fowkes FG, Paleo UF, Franklin RC, Fürst T, Gabbe B, Gaffikin L, Gankpé FG, Geleijnse JM, Gessner BD, Gething P, Gibney KB, Giroud M, Giussani G, Gomez Dantes H, Gona P, González-Medina D, Gosselin RA, Gotay CC, Goto A, Gouda HN, Graetz N, Gugnani HC, Gupta R, Gupta R, Gutiérrez RA, Haagsma J, Hafezi-Nejad N, Hagan H, Halasa YA, Hamadeh RR, Hamavid H, Hammami M, Hancock J, Hankey GJ, Hansen GM, Hao Y, Harb HL, Haro JM, Havmoeller R, Hay SI, Hay RJ, Heredia-Pi IB, Heuton KR, Heydarpour P, Higashi H, Hijar M, Hoek HW, Hoffman HJ, Hosgood HD, Hossain M, Hotez PJ, Hoy DG, Hsairi M, Hu G, Huang C, Huang JJ, Husseini A, Huynh C, Iannarone ML, Iburg KM, Innos K, Inoue M, Islami F, Jacobsen KH, Jarvis DL, Jassal SK, Jee SH, Jeemon P, Jensen PN, Jha V, Jiang G, Jiang Y, Jonas JB, Juel K, Kan H, Karch A, Karema CK, Karimkhani C, Karthikeyan G, Kassebaum NJ, Kaul A, Kawakami N, Kazanjan K, Kemp AH, Kengne AP, Keren A, Khader YS, Khalifa SE, Khan EA, Khan G, Khang YH, Kieling C, Kim D, Kim S, Kim Y, Kinfu Y, Kinge JM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y, Kosen S, Krishnaswami S, Kuate Defo B, Kucuk Bicer B, Kuipers EJ, Kulkarni C, Kulkarni VS, Kumar GA, Kyu HH, Lai T, Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC, Larsson A, Lawrynowicz AE, Leasher JL, Leigh J, Leung R, Levitz CE, Li B, Li Y, Li Y, Lim SS, Lind M, Lipshultz SE, Liu S, Liu Y, Lloyd BK, Lofgren KT, Logroscino G, Looker KJ, Lortet-Tieulent J, Lotufo PA, Lozano R, Lucas RM, Lunevicius R, Lyons RA, Ma S, Macintyre MF, Mackay MT, Majdan M, Malekzadeh R, Marcenes W, Margolis DJ, Margono C, Marzan MB, Masci JR, Mashal MT, Matzopoulos R, Mayosi BM, Mazorodze TT, Mcgill NW, Mcgrath JJ, Mckee M, Mclain A, Meaney PA, Medina C, Mehndiratta MM, Mekonnen W, Melaku YA, Meltzer M, Memish ZA, Mensah GA, Meretoja A, Mhimbira FA, Micha R, Miller TR, Mills EJ, Mitchell PB, Mock CN, Mohamed Ibrahim N, Mohammad KA, Mokdad AH, Mola GL, Monasta L, Montañez Hernandez JC, Montico M, Montine TJ, Mooney MD, Moore AR, Moradi-Lakeh M, Moran AE, Mori R, Moschandreas J, Moturi WN, Moyer ML, Mozaffarian D, Msemburi WT, Mueller UO, Mukaigawara M, Mullany EC, Murdoch ME, Murray J, Murthy KS, Naghavi M, Naheed A, Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KM, Nejjari C, Neupane SP, Newton CR, Ng M, Ngalesoni FN, Nguyen G, Nisar MI, Nolte S, Norheim OF, Norman RE, Norrving B, Nyakarahuka L, Oh IH, Ohkubo T, Ohno SL, Olusanya BO, Opio JN, Ortblad K, Ortiz A, Pain AW, Pandian JD, Panelo CI, Papachristou C, Park EK, Park JH, Patten SB, Patton GC, Paul VK, Pavlin BI, Pearce N, Pereira DM, Perez-Padilla R, Perez-Ruiz F, Perico N, Pervaiz A, Pesudovs K, Peterson CB, Petzold M, Phillips MR, Phillips BK, Phillips DE, Piel FB, Plass D, Poenaru D, Polinder S, Pope D, Popova S, Poulton RG, Pourmalek F, Prabhakaran D, Prasad NM, Pullan RL, Qato DM, Quistberg DA, Rafay A, Rahimi K, Rahman SU, Raju M, Rana SM, Razavi H, Reddy KS, Refaat A, Remuzzi G, Resnikoff S, Ribeiro AL, Richardson L, Richardus JH, Roberts DA, Rojas-Rueda D, Ronfani L, Roth GA, Rothenbacher D, Rothstein DH, Rowley JT, Roy N, Ruhago GM, Saeedi MY, Saha S, Sahraian MA, Sampson UK, Sanabria JR, Sandar L, Santos IS, Satpathy M, Sawhney M, Scarborough P, Schneider IJ, Schöttker B, Schumacher AE, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serina PT, Servan-Mori EE, Shackelford KA, Shaheen A, Shahraz S, Shamah Levy T, Shangguan S, She J, Sheikhbahaei S, Shi P, Shibuya K, Shinohara Y, Shiri R, Shishani K, Shiue I, Shrime MG, Sigfusdottir ID, Silberberg DH, Simard EP, Sindi S, Singh A, Singh JA, Singh L, Skirbekk V, Slepak EL, Sliwa K, Soneji S, Søreide K, Soshnikov S, Sposato LA, Sreeramareddy CT, Stanaway JD, Stathopoulou V, Stein DJ, Stein MB, Steiner C, Steiner TJ, Stevens A, Stewart A, Stovner LJ, Stroumpoulis K, Sunguya BF, Swaminathan S, Swaroop M, Sykes BL, Tabb KM, Takahashi K, Tandon N, Tanne D, Tanner M, Tavakkoli M, Taylor HR, Te Ao BJ, Tediosi F, Temesgen AM, Templin T, Ten Have M, Tenkorang EY, Terkawi AS, Thomson B, Thorne-Lyman AL, Thrift AG, Thurston GD, Tillmann T, Tonelli M, Topouzis F, Toyoshima H, Traebert J, Tran BX, Trillini M, Truelsen T, Tsilimbaris M, Tuzcu EM, Uchendu US, Ukwaja KN, Undurraga EA, Uzun SB, Van Brakel WH, Van De Vijver S, van Gool CH, Van Os J, Vasankari TJ, Venketasubramanian N, Violante FS, Vlassov VV, Vollset SE, Wagner GR, Wagner J, Waller SG, Wan X, Wang H, Wang J, Wang L, Warouw TS, Weichenthal S, Weiderpass E, Weintraub RG, Wenzhi W, Werdecker A, Westerman R, Whiteford HA, Wilkinson JD, Williams TN, Wolfe CD, Wolock TM, Woolf AD, Wulf S, Wurtz B, Xu G, Yan LL, Yano Y, Ye P, Yentür GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Yu C, Zaki ME, Zhao Y, Zheng Y, Zonies D, Zou X, Salomon JA, Lopez AD, Vos T. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (London, England). 2015 Nov 28:386(10009):2145-91. doi: 10.1016/S0140-6736(15)61340-X. Epub 2015 Aug 28     [PubMed PMID: 26321261]

Level 2 (mid-level) evidence

[2]

Weaver VM, Fadrowski JJ, Jaar BG. Global dimensions of chronic kidney disease of unknown etiology (CKDu): a modern era environmental and/or occupational nephropathy? BMC nephrology. 2015 Aug 19:16():145. doi: 10.1186/s12882-015-0105-6. Epub 2015 Aug 19     [PubMed PMID: 26282933]


[3]

Almaguer M, Herrera R, Orantes CM. Chronic kidney disease of unknown etiology in agricultural communities. MEDICC review. 2014 Apr:16(2):9-15. doi: 10.37757/MR2014.V16.N2.3. Epub     [PubMed PMID: 24878644]


[4]

Jayasumana C, Orantes C, Herrera R, Almaguer M, Lopez L, Silva LC, Ordunez P, Siribaddana S, Gunatilake S, De Broe ME. Chronic interstitial nephritis in agricultural communities: a worldwide epidemic with social, occupational and environmental determinants. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2017 Feb 1:32(2):234-241. doi: 10.1093/ndt/gfw346. Epub     [PubMed PMID: 28186530]


[5]

Gadde P, Sanikommu S, Manumanthu R, Akkaloori A. Uddanam nephropathy in India: a challenge for epidemiologists. Bulletin of the World Health Organization. 2017 Dec 1:95(12):848-849. doi: 10.2471/BLT.17.196758. Epub 2017 Oct 3     [PubMed PMID: 29200526]


[6]

Orantes-Navarro CM, Herrera-Valdés R, Almaguer-López M, López-Marín L, Vela-Parada XF, Hernandez-Cuchillas M, Barba LM. Toward a Comprehensive Hypothesis of Chronic Interstitial Nephritis in Agricultural Communities. Advances in chronic kidney disease. 2017 Mar:24(2):101-106. doi: 10.1053/j.ackd.2017.01.001. Epub     [PubMed PMID: 28284375]

Level 3 (low-level) evidence

[7]

Herrera Valdés R, Orantes CM, Almaguer López M, López Marín L, Arévalo PA, Smith González MJ, Morales FE, Bacallao R, Bayarre HD, Vela Parada XF. Clinical characteristics of chronic kidney disease of non-traditional causes in women of agricultural communities in El Salvador. Clinical nephrology. 2015:83(7 Suppl 1):56-63     [PubMed PMID: 25725244]


[8]

Athuraliya NT, Abeysekera TD, Amerasinghe PH, Kumarasiri R, Bandara P, Karunaratne U, Milton AH, Jones AL. Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka. Kidney international. 2011 Dec:80(11):1212-21. doi: 10.1038/ki.2011.258. Epub 2011 Aug 10     [PubMed PMID: 21832982]


[9]

Bandara JM, Senevirathna DM, Dasanayake DM, Herath V, Bandara JM, Abeysekara T, Rajapaksha KH. Chronic renal failure among farm families in cascade irrigation systems in Sri Lanka associated with elevated dietary cadmium levels in rice and freshwater fish (Tilapia). Environmental geochemistry and health. 2008 Oct:30(5):465-78. doi: 10.1007/s10653-007-9129-6. Epub 2008 Jan 17     [PubMed PMID: 18200439]


[10]

Wanigasuriya KP, Peiris-John RJ, Wickremasinghe R, Hittarage A. Chronic renal failure in North Central Province of Sri Lanka: an environmentally induced disease. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007 Oct:101(10):1013-7     [PubMed PMID: 17643458]


[11]

Chandrajith R, Dissanayake CB, Ariyarathna T, Herath HM, Padmasiri JP. Dose-dependent Na and Ca in fluoride-rich drinking water--another major cause of chronic renal failure in tropical arid regions. The Science of the total environment. 2011 Jan 15:409(4):671-5. doi: 10.1016/j.scitotenv.2010.10.046. Epub 2010 Nov 24     [PubMed PMID: 21109289]


[12]

Lebov JF, Engel LS, Richardson D, Hogan SL, Hoppin JA, Sandler DP. Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health Study. Occupational and environmental medicine. 2016 Jan:73(1):3-12. doi: 10.1136/oemed-2014-102615. Epub 2015 Jul 15     [PubMed PMID: 26177651]


[13]

Enan E, Matsumura F. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides. Biochemical pharmacology. 1992 Apr 15:43(8):1777-84     [PubMed PMID: 1315545]


[14]

Siriwardhana EA, Perera PA, Sivakanesan R, Abeysekara T, Nugegoda DB, Jayaweera JA. Dehydration and malaria augment the risk of developing chronic kidney disease in Sri Lanka. Indian journal of nephrology. 2015 May-Jun:25(3):146-51. doi: 10.4103/0971-4065.140712. Epub     [PubMed PMID: 26060363]


[15]

Torres C, Aragón A, González M, López I, Jakobsson K, Elinder CG, Lundberg I, Wesseling C. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2010 Mar:55(3):485-96. doi: 10.1053/j.ajkd.2009.12.012. Epub 2010 Feb 8     [PubMed PMID: 20116154]

Level 3 (low-level) evidence

[16]

Paula Santos U, Zanetta DM, Terra-Filho M, Burdmann EA. Burnt sugarcane harvesting is associated with acute renal dysfunction. Kidney international. 2015 Apr:87(4):792-9. doi: 10.1038/ki.2014.306. Epub 2014 Sep 17     [PubMed PMID: 25229334]


[17]

Roncal-Jimenez C, Lanaspa MA, Jensen T, Sanchez-Lozada LG, Johnson RJ. Mechanisms by Which Dehydration May Lead to Chronic Kidney Disease. Annals of nutrition & metabolism. 2015:66 Suppl 3():10-3. doi: 10.1159/000381239. Epub 2015 Jun 18     [PubMed PMID: 26088040]


[18]

Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA, Cicerchi C, Inaba S, Le M, Miyazaki M, Glaser J, Correa-Rotter R, González MA, Aragón A, Wesseling C, Sánchez-Lozada LG, Johnson RJ. Fructokinase activity mediates dehydration-induced renal injury. Kidney international. 2014 Aug:86(2):294-302. doi: 10.1038/ki.2013.492. Epub 2013 Dec 11     [PubMed PMID: 24336030]


[19]

Vervaet BA, Nast CC, Jayasumana C, Schreurs G, Roels F, Herath C, Kojc N, Samaee V, Rodrigo S, Gowrishankar S, Mousson C, Dassanayake R, Orantes CM, Vuiblet V, Rigothier C, D'Haese PC, De Broe ME. Chronic interstitial nephritis in agricultural communities is a toxin-induced proximal tubular nephropathy. Kidney international. 2020 Feb:97(2):350-369. doi: 10.1016/j.kint.2019.11.009. Epub 2019 Nov 23     [PubMed PMID: 31892415]


[20]

Athuraliya TN, Abeysekera DT, Amerasinghe PH, Kumarasiri PV, Dissanayake V. Prevalence of chronic kidney disease in two tertiary care hospitals: high proportion of cases with uncertain aetiology. The Ceylon medical journal. 2009 Mar:54(1):23-5     [PubMed PMID: 19391454]

Level 3 (low-level) evidence

[21]

Jayatilake N, Mendis S, Maheepala P, Mehta FR, CKDu National Research Project Team. Chronic kidney disease of uncertain aetiology: prevalence and causative factors in a developing country. BMC nephrology. 2013 Aug 27:14():180. doi: 10.1186/1471-2369-14-180. Epub 2013 Aug 27     [PubMed PMID: 23981540]


[22]

Benghanem Gharbi M, Elseviers M, Zamd M, Belghiti Alaoui A, Benahadi N, Trabelssi el H, Bayahia R, Ramdani B, De Broe ME. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD. Kidney international. 2016 Jun:89(6):1363-71. doi: 10.1016/j.kint.2016.02.019. Epub 2016 Apr 13     [PubMed PMID: 27165829]


[23]

Ordunez P, Nieto FJ, Martinez R, Soliz P, Giraldo GP, Mott SA, Hoy WE. Chronic kidney disease mortality trends in selected Central America countries, 1997-2013: clues to an epidemic of chronic interstitial nephritis of agricultural communities. Journal of epidemiology and community health. 2018 Apr:72(4):280-286. doi: 10.1136/jech-2017-210023. Epub 2018 Feb 2     [PubMed PMID: 29437864]


[24]

Orantes Navarro CM, Herrera Valdés R, López MA, Calero DJ, Fuentes de Morales J, Alvarado Ascencio NP, Vela Parada XF, Zelaya Quezada SM, Granados Castro DV, Orellana de Figueroa P. Epidemiological characteristics of chronic kidney disease of non-traditional causes in women of agricultural communities of El Salvador. Clinical nephrology. 2015:83(7 Suppl 1):24-31     [PubMed PMID: 25725238]

Level 2 (mid-level) evidence

[25]

Herrera Valdés R, Almaguer López M, Orantes Navarro CM, López Marín L, Brizuela Díaz EG, Bayarre Vea H, Amaya Medina JC, Silva Ayçaguer LC, Vela Parada XF, Zelaya Quezada S, Orellana de Figueroa P, Smith González M, Chávez Muñoz Y, García Ortiz XA, Bacallao Méndez R. Chronic interstitial nephritis of nontraditional causes in Salvadoran agricultural communities. Clinical nephrology. 2020 Supplement-Jan:93(1):60-67. doi: 10.5414/CNP92S110. Epub     [PubMed PMID: 31699212]


[26]

Paidi G, Iroshani Jayarathna AI, Salibindla DBAMR, Amirthalingam J, Karpinska-Leydier K, Alshowaikh K, Ergin HE. Chronic Kidney Disease of Unknown Origin: A Mysterious Epidemic. Cureus. 2021 Aug:13(8):e17132. doi: 10.7759/cureus.17132. Epub 2021 Aug 12     [PubMed PMID: 34548965]


[27]

Herath C, Jayasumana C, De Silva PMCS, De Silva PHC, Siribaddana S, De Broe ME. Kidney Diseases in Agricultural Communities: A Case Against Heat-Stress Nephropathy. Kidney international reports. 2018 Mar:3(2):271-280. doi: 10.1016/j.ekir.2017.10.006. Epub 2017 Oct 24     [PubMed PMID: 29725631]

Level 3 (low-level) evidence

[28]

Nanayakkara S, Senevirathna ST, Abeysekera T, Chandrajith R, Ratnatunga N, Gunarathne ED, Yan J, Hitomi T, Muso E, Komiya T, Harada KH, Liu W, Kobayashi H, Okuda H, Sawatari H, Matsuda F, Yamada R, Watanabe T, Miyataka H, Himeno S, Koizumi A. An integrative study of the genetic, social and environmental determinants of chronic kidney disease characterized by tubulointerstitial damages in the North Central Region of Sri Lanka. Journal of occupational health. 2014:56(1):28-38     [PubMed PMID: 24351856]


[29]

Ordunez P, Saenz C, Martinez R, Chapman E, Reveiz L, Becerra F. The epidemic of chronic kidney disease in Central America. The Lancet. Global health. 2014 Aug:2(8):e440-1. doi: 10.1016/S2214-109X(14)70217-7. Epub 2014 Jun 24     [PubMed PMID: 25103508]


[30]

Orantes-Navarro CM, Almaguer-López MM, Alonso-Galbán P, Díaz-Amaya M, Hernández S, Herrera-Valdés R, Silva-Aycaguer LC. The Chronic Kidney Disease Epidemic in El Salvador: A Cross-Sectional Study. MEDICC review. 2019 Apr-Jul:21(2-3):29-37. doi: 10.37757/MR2019.V21.N2-3.7. Epub     [PubMed PMID: 31373582]

Level 2 (mid-level) evidence

[31]

Orantes CM, Herrera R, Almaguer M, Brizuela EG, Núñez L, Alvarado NP, Fuentes EJ, Bayarre HD, Amaya JC, Calero DJ, Vela XF, Zelaya SM, Granados DV, Orellana P. Epidemiology of chronic kidney disease in adults of Salvadoran agricultural communities. MEDICC review. 2014 Apr:16(2):23-30. doi: 10.37757/MR2014.V16.N2.5. Epub     [PubMed PMID: 24878646]


[32]

Orantes CM, Herrera R, Almaguer M, Brizuela EG, Hernández CE, Bayarre H, Amaya JC, Calero DJ, Orellana P, Colindres RM, Velázquez ME, Núñez SG, Contreras VM, Castro BE. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa study, 2009. MEDICC review. 2011 Oct:13(4):14-22. doi: 10.37757/MR2011V13.N4.5. Epub     [PubMed PMID: 22143603]


[33]

Herrera R, Orantes CM, Almaguer M, Alfonso P, Bayarre HD, Leiva IM, Smith MJ, Cubias RA, Torres CG, Almendárez WO, Cubias FR, Morales FE, Magaña S, Amaya JC, Perdomo E, Ventura MC, Villatoro JF, Vela XF, Zelaya SM, Granados DV, Vela E, Orellana P, Hevia R, Fuentes EJ, Mañalich R, Bacallao R, Ugarte M, Arias MI, Chávez J, Flores NE, Aparicio CE. Clinical characteristics of chronic kidney disease of nontraditional causes in Salvadoran farming communities. MEDICC review. 2014 Apr:16(2):39-48. doi: 10.37757/MR2014.V16.N2.7. Epub     [PubMed PMID: 24878648]


[34]

Noiri C, Shimizu T, Takayanagi K, Tayama Y, Iwashita T, Okazaki S, Hatano M, Matsumura O, Kato H, Matsuda A, Mitarai T, Hasegawa H. Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. Clinical and experimental nephrology. 2015 Dec:19(6):1071-8. doi: 10.1007/s10157-015-1099-x. Epub 2015 Feb 28     [PubMed PMID: 25724126]


[35]

Shargorodsky J, Curhan SG, Henderson E, Eavey R, Curhan GC. Heavy metals exposure and hearing loss in US adolescents. Archives of otolaryngology--head & neck surgery. 2011 Dec:137(12):1183-9. doi: 10.1001/archoto.2011.202. Epub     [PubMed PMID: 22183895]


[36]

Cabrera J WE, Vervaet BA, Schreurs G, Nast CC, Santa-Cruz F, De Broe ME. Chronic Interstitial Nephritis in Agricultural Communities: A Patient in Paraguay. Kidney international reports. 2022 May:7(5):1131-1135. doi: 10.1016/j.ekir.2022.02.019. Epub 2022 Mar 4     [PubMed PMID: 35570993]


[37]

Abdul KSM, De Silva PMCS, Ekanayake EMDV, Thakshila WAKG, Gunarathna SD, Gunasekara TDKSC, Jayasinghe SS, Asanthi HB, Chandana EPS, Chaminda GGT, Siribaddana SH, Jayasundara N. Occupational Paraquat and Glyphosate Exposure May Decline Renal Functions among Rural Farming Communities in Sri Lanka. International journal of environmental research and public health. 2021 Mar 22:18(6):. doi: 10.3390/ijerph18063278. Epub 2021 Mar 22     [PubMed PMID: 33810013]


[38]

Rodrigo C, Nawarathne P, Jayasinghe S. Chronic interstitial nephritis in agricultural communities (CINAC) and lysosomal tubulopathy: Is there a place for anti-oxidants? Medical hypotheses. 2021 Jan:146():110414. doi: 10.1016/j.mehy.2020.110414. Epub 2020 Nov 22     [PubMed PMID: 33268000]


[39]

Jayasumana C, Ranasinghe O, Ranasinghe S, Siriwardhana I, Gunatilake S, Siribaddana S. Reverse osmosis plant maintenance and efficacy in chronic kidney disease endemic region in Sri Lanka. Environmental health and preventive medicine. 2016 Nov:21(6):591-596     [PubMed PMID: 27744596]


[40]

Wesseling C, van Wendel de Joode B, Crowe J, Rittner R, Sanati NA, Hogstedt C, Jakobsson K. Mesoamerican nephropathy: geographical distribution and time trends of chronic kidney disease mortality between 1970 and 2012 in Costa Rica. Occupational and environmental medicine. 2015 Oct:72(10):714-21. doi: 10.1136/oemed-2014-102799. Epub 2015 Jul 21     [PubMed PMID: 26199395]


[41]

Moledina DG, Obeid W, Smith RN, Rosales I, Sise ME, Moeckel G, Kashgarian M, Kuperman M, Campbell KN, Lefferts S, Meliambro K, Bitzer M, Perazella MA, Luciano RL, Pober JS, Cantley LG, Colvin RB, Wilson FP, Parikh CR. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. The Journal of clinical investigation. 2023 Jul 3:133(13):. doi: 10.1172/JCI168950. Epub 2023 Jul 3     [PubMed PMID: 37395276]

Level 1 (high-level) evidence